4-(bromomethyl)-N-methylpyridine-2-carboxamide | 872706-94-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-(bromomethyl)-N-methylpyridine-2-carboxamide
• CAS: 872706-94-0
• 化学式: C₈H₉BrN₂O
• 分子量: 229.076
• InChiKey: VRNYYAGVICQHAR-UHFFFAOYSA-N

物化性质

• 沸点：
  380.7±32.0 °C(Predicted)
• 密度：
  1.502±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(bromomethyl)-N-methylpyridine-2-carboxamide 在 5%-palladium/activated carbon 、 氢气 、 sodium hydride 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.5h， 生成
  参考文献：
  名称：

  Design, synthesis and biological evaluation of indole derivatives as novel inhibitors targeting B-Raf kinase

  摘要：

  A series of novel indole derivatives were designed and synthesized and their inhibitory activity against B-Raf and HepG2 cell were also described. Among them, compounds 7a and 7b exhibited excellent potency, which showed the potential for further research as lead compounds. (C) 2013 Wei-Fang Tang and Tao Lu. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.

  DOI：

  10.1016/j.cclet.2013.11.006
• 作为产物：
  描述：

  (2-甲基氨基羰基-4-吡啶基)甲醇 在 四溴化碳 、 三苯基膦 作用下， 以 四氢呋喃 为溶剂， 以4.79 %的产率得到4-(bromomethyl)-N-methylpyridine-2-carboxamide
  参考文献：
  名称：

  [EN] STIMULATOR OF INTERFERON GENES (STING) MODULATORS, AND COMPOSITIONS AND METHODS THEREOF
  [FR] MODULATEURS DE STIMULATEUR DE GÈNES D'INTERFÉRON (STING), ET COMPOSITIONS ET MÉTHODES ASSOCIÉES

  摘要：

  The invention provides novel modulators of STING (Stimulator of Interferon Genes) and pharmaceutical compositions thereof, as well as methods of their preparation and use, in therapy of various diseases and conditions, such as cancer, infectious and autoimmune diseases or disorders.

  公开号：

  WO2023158862A2

文献信息

• NOVEL OXADIAZOLE DERIVATIVES AND THIADIAZOLE DERIVATIVES HAVING NEOVASCULARIZATION INHIBITORY ACTIVITY
  申请人：Honda Takahiro

  公开号：US20100016354A1

  公开（公告）日：2010-01-21

  The present invention relates to Compounds represented by the formula (I) or salts thereof. In the formula (I), the ring A represents a benzene ring, a thiophene ring, or a pyridine ring; R a represents a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group; the ring B represents a pyridine ring, a pyrimidine ring, or a quinoline ring; the ring C represents a benzene ring; a pyridine ring, a quinoline ring, or an isoquinoline ring; X and Y, the same or different, represent an oxygen atom or a sulfur atom, with the proviso that the case X is a sulfur atom and Y is an oxygen atom be excluded; R 1 represents a hydrogen atom, a halogen atom, an amino group, a cycloalkylamino group, an alkylcarbonylamino group, an alkyloxycarbonylamino group, an alkylaminocarbonyl group, or a non-aromatic heterocyclic group; and R 2 and R 2 ′, the same or different, represent a hydrogen atom, a halogen atom, an alkyl group, a halogeno-alkyl group, or a halogeno-alkoxy group.

  本发明涉及由式（I）表示的化合物或其盐。在式（I）中，环A表示苯环，噻吩环或吡啶环；R表示氢原子，卤素原子，烷基或烷氧基；环B表示吡啶环，嘧啶环或喹啉环；环C表示苯环，吡啶环，喹啉环或异喹啉环；X和Y，相同或不同，表示氧原子或硫原子，但X是硫原子且Y是氧原子的情况除外；R1表示氢原子，卤素原子，氨基，环烷基氨基，烷基羰基氨基，烷氧羰基氨基，烷基氨基甲酰基或非芳香族杂环基；而R2和R2'，相同或不同，表示氢原子，卤素原子，烷基，卤代烷基或卤代烷氧基。
• 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
  申请人：Brennan Catherine

  公开号：US20080293696A1

  公开（公告）日：2008-11-27

  A compound having the formula (1) in which the ring containing E is a phenyl, a pyridine, or a pyrimidine. In formula (1) the symbol A represents wherein the group R 4 represents halogen, CF 3 , or H, provided that the maximum number of CF 3 groups on any A is 2, and the maximum number of hydrogens on A is 2 for the A groups which together with the carbon atoms to which they are attached form 6-membered rings, and the maximum number of hydrogens on A is 1 for the A group which together with the carbon atoms to which it is attached forms a 5-membered ring. Z represents N or CH when E forms a phenyl ring, and represents CH when E forms a pyridine or pyrimidine. The groups R 1 , R 2 and R 3 and the subscripts a, b, and d are as defined in the text and claims. Pharmaceutical compositions containing a compound of formula (1) and methods of treating cancer using compounds of formula (1) are also disclosed and claimed.

  化合物的化学式为(1)，其中含有E的环为苯环、吡啶环或嘧啶环。在公式(1)中，符号A代表，其中基团R4代表卤素、CF3或H，前提是任何A上CF3基团的最大数量为2，且与它们连接的碳原子形成6元环的A组的氢原子的最大数量为2，与它们连接的碳原子形成5元环的A组的氢原子的最大数量为1。当E形成苯环时，Z代表N或CH，当E形成吡啶环或嘧啶环时，Z代表CH。基团R1、R2和R3及下标a、b和d如所述和要求中定义。还披露和声明了含有化合物(1)的制药组合物和使用化合物(1)治疗癌症的方法。
• NOVEL OXADIAZOLE DERIVATIVES AND THIADIAZOLE DERIVATIVES HAVING NEOVASCULARIZATION INHIBITING ACTIVITY
  申请人：Santen Pharmaceutical Co., Ltd

  公开号：EP2128156A1

  公开（公告）日：2009-12-02

  The present invention relates to Compounds represented by the formula (I) or salts thereof. In the formula (I), the ring A represents a benzene ring, a thiophene ring, or a pyridine ring; Ra represents a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group; the ring B represents a pyridine ring, a pyrimidine ring, or a quinoline ring; the ring C represents a benzene ring, a pyridine ring, a quinoline ring, or an isoquinoline ring; X and Y, the same or different, represent an oxygen atom or a sulfur atom, with the proviso that the case X is a sulfur atom and Y is an oxygen atom be excluded; R1 represents a hydrogen atom, a halogen atom, an amino group, a cycloalkylamino group, an alkylcarbonylamino group, an alkyloxycarbonylamino group, an alkylaminocarbonyl group, or a non-aromatic heterocyclic group; and R2 and R2', the same or different, represent a hydrogen atom, a halogen atom, an alkyl group, a halogeno-alkyl group, or a halogeno-alkoxy group.

  本发明涉及式（I）所代表的化合物或其盐类。在式 (I) 中，环 A 代表苯环、噻吩环或吡啶环；Ra 代表氢原子、卤素原子、烷基或烷氧基；环 B 代表吡啶环、嘧啶环或喹啉环；环 C 代表苯环、吡啶环、喹啉环或异喹啉环；X 和 Y 相同或不同，代表氧原子或硫原子，但不包括 X 为硫原子而 Y 为氧原子的情况；R1 代表氢原子、卤素原子、氨基、环烷基氨基、烷基羰基氨基、烷氧基羰基氨基、烷基氨基羰基或非芳香杂环基团；R2 和 R2'相同或不同，代表氢原子、卤素原子、烷基、卤代烷基或卤代烷氧基。
• [EN] 2-AMINOTHIOPHENECARBOXAMIDES USEFUL AS CANCER CHEMOTHERAPEUTIC AGENTS<br/>[FR] UTILISATION DE 2-AMINOTHIOPHENECARBOXAMIDES COMME AGENTS CHIMIOTHERAPEUTIQUES DANS LE TRAITEMENT DU CANCER
  申请人：BAYER PHARMACEUTICALS CORP

  公开号：WO2006023707A3

  公开（公告）日：2006-07-13
• [EN] 2-AMINOARYLCARBOXAMIDES USEFUL AS CANCER CHEMOTHERAPEUTIC AGENTS<br/>[FR] 2-AMINOARYLCARBOXAMIDES UTILES COMME AGENTS CHIMIOTHERAPEUTIQUES CONTRE LE CANCER
  申请人：BAYER PHARMACEUTICALS CORP

  公开号：WO2006002383A3

  公开（公告）日：2006-08-17